LAWRENCE, Mass., Aug. 15, 2011 /PRNewswire/ — NxStage®
Medical, Inc. (Nasdaq:
NXTM), a leading manufacturer of innovative dialysis products,
is celebrating Indiana University Health’s (IU Health) seventh
anniversary of its program to offer home hemodialysis to patients
with the NxStage System One™. IU Health started its
home dialysis program by partnering with NxStage on its
Investigational Device Exemption (IDE) study for U.S. Food and Drug
Administration (FDA) clearance to market the System One for home
use. In addition, three IU Health patients who were among the first
ever to receive dialysis with the System One, are celebrating more
than seven years with the therapy.
(Logo:
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)
Long-time dialysis patient Rick Skiles, 57, had tried numerous
treatment modalities when he learned about NxStage’s clinical trial
study at IU Health in 2004. Skiles enrolled and became the first
patient in Indiana to train on the NxStage System One. More than
seven years later, the flexibility to do his treatments on his own
time and the health benefits he has realized thanks to more
frequent treatments have helped Skiles lead a liberated, healthy
life. “I feel extremely fortunate as a patient at IU Health to have
had the opportunity to be among the first daily home hemodialysis
patients,” says Skiles. “With the System One, I felt I got my life
back, and I look forward to many active, healthy years to come with
this therapy.”
“We applaud healthcare providers and partners such as IU Health
for helping to pioneer daily home hemodialysis with the NxStage
System One,” said Jeffrey H. Burbank, Chief Executive Officer of
NxStage Medical. “Because of their leadership, enthusiasm, and
continued commitment to advancing renal care, a growing number of
dialysis patients like Rick are realizing the life-changing
benefits po
‘/>”/>
